Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5278702
Max Phase: Preclinical
Molecular Formula: C35H53NO7S
Molecular Weight: 631.88
Associated Items:
ID: ALA5278702
Max Phase: Preclinical
Molecular Formula: C35H53NO7S
Molecular Weight: 631.88
Associated Items:
Canonical SMILES: C/C=C(C)/C=C(\C)[C@@H](O)[C@H](C)[C@@H](O)[C@H](O)[C@@H]1C/C=C\C=C\[C@@H](O)C[C@H](O)[C@@H](C)c2nc(cs2)/C=C(\CCCCCC)C(=O)O1
Standard InChI: InChI=1S/C35H53NO7S/c1-7-9-10-12-15-26-19-27-21-44-34(36-27)24(5)29(38)20-28(37)16-13-11-14-17-30(43-35(26)42)33(41)32(40)25(6)31(39)23(4)18-22(3)8-2/h8,11,13-14,16,18-19,21,24-25,28-33,37-41H,7,9-10,12,15,17,20H2,1-6H3/b14-11-,16-13+,22-8+,23-18+,26-19+/t24-,25+,28-,29+,30+,31-,32-,33-/m1/s1
Standard InChI Key: CGUNOWXWUXNOPE-VHIBFKCNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 631.88 | Molecular Weight (Monoisotopic): 631.3543 | AlogP: 5.77 | #Rotatable Bonds: 11 |
Polar Surface Area: 140.34 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 13.04 | CX Basic pKa: 2.25 | CX LogP: 5.61 | CX LogD: 5.61 |
Aromatic Rings: 1 | Heavy Atoms: 44 | QED Weighted: 0.12 | Np Likeness Score: 2.01 |
1. Zhang HZ, Zhao ZL, Zhou CH.. (2018) Recent advance in oxazole-based medicinal chemistry., 144 [PMID:29288945] [10.1016/j.ejmech.2017.12.044] |
Source(1):